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Abstract
Lo scopo di questa tesi è lo studio degli aspetti procedurali e dosimetrici in
angiografie periferiche che utilizzano la CO2 come mezzo di contrasto.
La tecnica angiografica consiste nell’imaging radiologico di vasi sanguigni tramite
l’iniezione di un mezzo di contrasto, e il suo uso è in costante incremento a
causa dell’aumento di pazienti con malattie vascolari. I mezzi di contrasto iodati
sono i più comunemente utilizzati e permettono di ottenere immagini di ottima
qualità, ma presentano il limite di una elevata nefrotossicità. La CO2 è considerata
un’interessante alternativa al mezzo iodato, per la sua acclarata biocompatibilità,
soprattutto per pazienti con elevati fattori di rischio (diabete e/o insufficienza re-
nale). Il suo utilizzo presenta comunque alcuni aspetti problematici, dovuti allo
stato gassoso e al basso contrasto intrinseco rispetto alla soluzione iodata. Per
quest’ultimo motivo si ritiene generalmente che l’utilizzo della CO2 comporti un
aumento di dose rispetto ai mezzi di contrasto tradizionali.
Il nostro studio, effettuato su diversi apparati radiologici, ha dimostrato che
i parametri di emissione radiologica sono gli stessi per i protocolli di angiografia
tradizionale, con iodio, e quelli che utilizzano CO2. Questa evidenza suggerisce che
i protocolli CO2 operino solo sul trattamento delle immagini ottenute e non sulla
modalità di acquisizione, e dal punto di vista dosimetrico l’angiografia con CO2 è
riconducibile all’angiografia tradizionale. L’unico fattore che potrebbe portare a
un effettivo incremento di dose al paziente è un allungamento dei tempi di scopia
e di procedura, che andrebbe verificato con una campagna di misure in ambito
clinico.
Sulla base della stessa evidenza, si ritiene che la visualizzazione della CO2 possa
essere ulteriormente migliorata attraverso l’ottimizzazione dei parametri di emis-
sione radiologica (kVp, frame rate e durata degli impulsi) attualmente predisposti
per l’uso di mezzi di contrasto iodati.
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Introduction
Angiography is an important radiological imaging technique that allows
the visualization of blood vessels through the injection of a contrast medium.
Peripheral angiography, in particular, is a powerful instrument for the treat-
ment of vascular diseases. However, an increasing number of patients presents
high risk factors for the use of traditional iodinated contrast media. These
include diabetes, renal diseases, allergies and very young or old age.
Carbon dioxide represents an interesting alternative for these patients,
thanks to its lack of allergic reactions and renal toxicity. Along with a num-
ber of advantages, however, the use of a gaseous contrast media entails a
series of technical issues. Difficulties in controlling its delivery and the risk
of air contamination could be reduced through the introduction of innovative
delivery systems, such as automatic injectors. Because of its X-ray absorp-
tion characteristics, CO2 provides less contrast than iodinated contrast me-
dia, and for this reason it is generally believed to require higher doses than
traditional angiographies.
In this work we addressed the dosimetric aspects of CO2 angiography by
studying the image acquisition protocols for both traditional and CO2-based
peripheral angiography on different fluoroscopy equipment.
The first chapter gives an overview of the problem, briefly introducing the
angiographic technique, contrast media, fluoroscopy systems and some basic
notions on radiological protection in medical exposures. The second chapter
is devoted to the presentation of the considered instrumentation, while in the
following chapters we illustrate and discuss the results of our measures.
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CHAPTER 1
Overview of the problem
1.1 Angiography
Angiography is a medical imaging technique performed to visualise blood
vessels, in order to detect eventual abnormalities or blockages throughout
the circulatory system and in some organs. The procedure is commonly
used to identify conditions that affect the vessels and the blood flow, such
as atherosclerosis, heart diseases or aneurysms, to give surgeons an accurate
“map” of blood vessels prior to surgery, and many other applications.
Angiographies have a fundamental role in interventional radiology (IR),
the branch of radiology that comprises image-guided therapeutic interven-
tions. Over the last few decades this field has become increasingly important,
and the types and complexity of the procedures have greatly expanded [1].
Angiograms are routinely performed during interventional radiology proce-
dures, to guide the radiologist in the insertion of catheters, guidewires and
stents.
The angiographic technique has multiple applications, such as abdominal
angiographies, cerebral angiographies and peripheral angiographies [2]. In
particular, peripheral angiography is a steadily growing field, due to the
increase of the number of patients with Peripheral Vascular Disease. PVD is
a very common condition that usually develops as a result of atherosclerosis,
a hardening of the arteries that occurs when cholesterol and scar tissue build
up. The clogged arteries cause decreased blood flow to the legs, which can
result in pain when walking and, if not properly treated, could eventually
lead to gangrene and amputation.
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1.1.1 Angiographic procedures
Angiographies require an adequate patient preparation. If the patient
has a history of contrast allergy or renal failure, an appropriate preparation
with steroid and hydration is usually recommended. Anaesthesia is avoided
since patients have to remain alert during the examination, so that they can
cooperate in holding their breath when needed, as respiratory motion might
contribute to motion blurring in the final images. Sedatives and analgesics
are instead used to alleviate the discomfort of the procedure and reduce
anxiety and restlessness.
Patients are precautionarily monitored throughout the procedure, gener-
ally with pulse oximetry, ECG, heart rate, respiratory rate and blood pres-
sure.
To perform the angiogram, the doctor inserts a catheter into the blood
vessel through a small incision or a wide needle. Depending on the purpose
of the procedure the insertion is made in different body parts, though the
most commonly used is the femoral artery. With the help of X-ray imaging,
the catheter is then carefully moved to the interested area.
Once the catheter is in place, angiographic image acquisition can start
and the radiologist injects a contrast agent through the catheter. In fact, as
both blood and soft tissues have a similar X-ray attenuation coefficients, a
contrast agent is necessary to outline the vessels. The choice of this contrast
medium is quite relevant and requires a careful evaluation of the contrasto-
graphic efficiency, the risks of adverse effects and also the cost.
Angiographic images are generally produced using a technique called digi-
tal subtraction angiography (DSA), that shows only the contrast-filled vessels
while suppressing other anatomical features such as bones and other organs.
While being extremely effective in most cases, DSA requires the patient to
remain motionless, hence it cannot be used for the heart. For procedures like
coronary angiography it is fundamental to use high frame rates, in order to
reduce motion blurring.
In the case of IR procedures, the interventional radiologist can treat the
patient without surgery at the same time the angiogram is performed.
During the procedure, both fluoroscopy and radiography are performed,
according to the different instances. For example, fluoroscopy is used for
a live monitoring of the catheter while radiography is mainly used to take
good-quality images for the patient’s medical record.
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Digital subtraction angiography
This technique increases the contrast of the blood vessels and reduces
anatomical noise by subtracting an image acquired before injecting the con-
trast media (mask) to the images acquired after the injection. All the images
undergo a log transform before subtraction, in order to obtain a final image
in which the signal only depends on the amount of contrast in the vessel and
not on the background.
Assuming that the patient has a thickness xt and a linear attenuation
coefficient of µt, the mask image can be modeled as:
Im = αI0e
−µtxt
where I0 is the photon fluence of the unattenuated radiation and α is a con-
version factor which relates image signal and photon fluence. This equation
derives from the Beer–Lambert law, hence it is only approximately correct
as the radiation is not monochromatic.
After the contrast injection, we consider a vessel of thickness xI (where xI  xt)
and linear attenuation coefficient of µI . The obtained image is:
II = αI0e
−(µtxt+µIxI)
If these images where linearly subtracted, the outcome would be an image
with this form:
Slin = Im − II = αI0e−(µtxt)[1− e−(µIxI)]
Assuming that the signal of the vessel is so small that µIxI << 1, we have:
Slin = α(µIxI)I0e
−(µtxt)
Therefore, using linear subtraction, we obtain an image in which the vessel
thickness xI is modulated by the patient thickness xt.
On the other hand, logarithmic subtraction does not retain such anatom-
ical structure. In fact the resulting image has this form:
Slog = ln(Im)− ln(II) ∼= [−µtxt]− [−µtxt − µIxI ] = µIxI
showing that the signal is not affected by the patient thickness or the anatomy
on which the opacified artery is superimposed.
The major source of artefacts in DSA is patient motion between the
capture of the different images. In some cases these artifacts can be reduced
through the use of processing techniques, such as pixel shifting of the mask
image.
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1.1.2 Iodinated contrast media (ICM)
The most commonly used contrast media are iodine-containing. These
are classified as positive contrast media, as they have a high atomic number
and appear more radiopaque than the surrounding tissues.
Currently used ICM are triiodinated benzoic acid derivatives, and can be
differentiated according to their physicochemical properties (iodine content,
osmolarity, level of ionization and degree of polymerization). ICMs can be
divided in four groups: ionic monomers, non-ionic monomers, ionic dimers,
and non-ionic dimers (fig.1.1)
Figure 1.1: Classification of iodinated contrast agents [4].
The iodine to particle ratio is important, as it defines the relationship
between contrastographic efficacy and osmotic effect.
Ionic monomers have a low iodine-to-particle ratio, 1.5, and are thus classi-
fied as high-osmolar contrast media (HOCM). These are the most traditional
ICM, and are still in use because of their relatively low cost.
Both non-ionic monomers and ionic dimers have a ratio of 3, and are known
as low-osmolar contrast media (LOCM).
The newest ICM are non-ionic dimers which have a ratio of 6, and are called
iso-osmolar contrast media (IOCM) as their osmolarity similar to that of
blood plasma.
While HOCM are known to be more nephrotoxic than the others [3], it is
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still unclear whether all LOCM and IOCM have similar toxicities or not. In
particular, IOCM are not as safe as originally hoped, probably due to their
high viscosity.
Most of the contrast media is eliminated via the kidneys, and the elim-
ination half-life following intravascular administration is about 2 hours in
patients with normal renal function. In patients with renal impairment, on
the other hand, the excretion time is prolonged and can last for several weeks
[4]. The administration of iodinated contrast media can cause side effects in
7-8% of cases, with severe adverse reactions in 0.1% of patients [3].
The majority of these side effects are unpredictable and not dose-dependent,
and they can be classified as acute (if they occur immediately after the in-
jection) or delayed (if they appear after more than 1 hour but within 7 days
of contrast injection).
Acute contrast reactions can range from minor effects, that are usually of
short duration and do not require specific treatment (e.g. flushing, nau-
sea, pruritus, vomiting and headache), to severe and life-threatening reac-
tions such as convulsions, unconsciousness, laryngeal oedema, severe bron-
chospasm, pulmonary oedema, severe cardiac dysrhythmias and arrest, and
cardiovascular and pulmonary collapse.
Delayed reactions are generally mild and include fever, rash, flushing, dizzi-
ness, pruritus, arthralgia, diarrhoea, nausea, vomiting, headache and occa-
sionally hypotension. Nevertheless, there have been cases of serious delayed
reactions (e.g. shock, hypotension, angio-oedema and dyspnoea).
There are several predisposing factors that can increase the incidence of se-
vere contrast reactions, such as very young or old age, a history of allergy or
asthma and cardiac or renal disease.
A very important side effect due to the administration of contrast media
is the “contrast medium nephrotoxicity” (CMN), which is a reduction in renal
function in the absence of an alternative aetiology. Most episodes are self-
limiting and resolve within 1 or 2 weeks, and permanent renal damage is
rare.
The incidence of CMN is low in patients with normal renal function (from 0%
to 10%) but it increases in patients with renal problems (ranging from 12%
to 27%, as reported by several studies [4]). There are some known factors
that increase the risk of developing CMN: pre-existing renal impairment, as
stated above, especially when this reduction in renal function is secondary
to diabetic nephropathy; large doses of ICM; administration of ICM in the
renal arteries; dehydration; congestive cardiac failure; old age (over 70 years);
and the concurrent use of nephrotoxic drugs. The type of ICM also makes a
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difference, as high-osmolarity ICM are more nephrotoxic than those with a
lower osmolarity [6].
In patients with risk factors it is therefore important to take some measures
to reduce the severity of CMN, such as extracellular volume expansion (e.g.
intravenous administration of normal saline [7]) and use of low-osmolality
ICM.
ICM also have a relatively high viscosity, which makes it hard to inject
through small catheters and needles. For the same reason, some small vessels
will not be shown as the contrast media cannot pass through them or through
very tight stenoses.
Another issue with ICM is their elevated cost, especially for LOCM and
IOCM, to which one must add the costs of the cures that become necessary
in case of adverse effects [5].
1.1.3 Carbon dioxide as a contrast medium
Carbon dioxide (CO2) can be used as intravascular contrast agent, and
it is considered an interesting alternative to traditional ICM.
Due to its unique properties, such as the low viscosity and the lack of allergic
reactions and renal toxicity, it has become particularly helpful in patients
with compromised renal function or hypersensitivity to iodinated contrast
material. This contrast agent is also more advantageous than the traditional
ICM from an economical point of view, as medical-grade CO2 is practically
zero-cost. Its use is thus spreading even on patients with no particular risk
factors for traditional contrast media.
On the other hand, the use of CO2 presents some technical difficulties due
to its gaseous properties. Furthermore, ICM still represent the gold standard
for angiographic procedures, as they generally give better images.
Considering both its advantages and disadvantages, CO2 is gaining grow-
ing attention as a contrast media, not only as a complete replacement of
traditional ICM, but for their combined use.
The use of CO2 gas as an imaging agent dates back to 1914, and it was
routinely used in the 1950s and 1960s for the detection of pericardial effu-
sion. In the 1970s it was first used as an intra-arterial contrast agent, but it
became much more reliable after 1980, with the advent of DSA.
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Properties and potential complications
Unlike most liquid contrast agents, which mix with the blood and fill the
lumen, carbon dioxide is a gas that displaces the blood forming bubbles. CO2
is a negative contrast agent, as it absorbs X-rays to a lesser degree than the
surrounding tissues. For this reason CO2 angiographies look like a negative
version of the traditional ones, with white vessels on a darker background.
Figure 1.2: Linear attenuation coefficients of ICM, CO2 and soft tissue.
Figure 1.2 shows the linear attenuation coefficients of traditional ICM,
CO2 and soft tissue (ICRU-44) as functions of the radiation energy. It can
be clearly seen that, while iodine has a K-edge at 33 keV, CO2 has no notable
irregularities. The X-ray absorption of CO2 is roughly 1/10 of that obtained
with diluted iodine and, as it is not highly different from surrounding tissues,
it produces less contrast [12].
With the use of enhancement techniques such as DSA, however, it is
possible to obtain results with a diagnostic accuracy comparable to ICM in
a majority of cases (figure 1.3).
CO2 is 400 times less viscous than ICM [9]. This characteristic is a
great advantage for angiographies not only as it allows the quick injection
of large volumes of the gas through very small catheters, but it also allows
CO2 to pass through small vessels, visualise tight stenoses and collaterals,
and small bleeding. An example of this power is shown in figure 1.4: during
an intervention for the revascularisation of the anterior tibial artery, the
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Figure 1.3: Dorsalis pedis artery DSA, with ICM and CO2 respectively.
radiologist needs morphological informations on the vessels to decide if and
where it is possible to insert an angioplasty balloon catheter. In the first
image, obtained through traditional ICM angiography, the artery on the
right seems blocked: this may lead the radiologist to desist on unclogging
that particular vessel. In the second image, on the other hand, the artery is
clearly open on the bottom. In fact, thanks to its extremely low viscosity,
CO2 can easily pass through the clogged section of the artery, thus correctly
imaging to the rest of the vessel.
When CO2 is injected in a large vessel it cannot completely displace the
blood and, being lighter than blood plasma, it forms bubbles that flow along
the anterior part of the vessel. This is not a problem in small vessels, as CO2
angiography would not significantly underestimate the diameter of a vessel
as long as at least 50% of its luminal diameter is filled with the gas (the
luminal gas filling is usually greater than 70% in vessel sizes up to 15mm
[9]). Nevertheless, an incomplete filling will lead to non-optimal contrast.
The gas buoyancy may also cause preferential filling of some branches, based
on patient positioning. It is therefore fundamental to carefully choose the pa-
tient’s position, and eventually to change it as suitable during the procedure.
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Figure 1.4: Anterior tibial artery revascularisation, with ICM and CO2.
A great advantage of the use of CO2 is that it causes no allergic reaction,
and experimental and clinical data also indicate that carbon dioxide causes
no renal toxicity nor hepatic toxicity. This makes it an ideal alternative to
ICM for patients with a history of allergic reactions, but also for patients
with diabetes or compromised renal function.
CO2 is considered safe for intravascular injections because of its high solu-
bility rate (being approximately 20 times more soluble in water than air [9]),
hence it does not lead to clinically significant gas embolism.
After the injection, bubbles rapidly flow into the heart and pulmonary
artery, and dissolved CO2 is completely removed by pulmonary expiration.
This process usually requires 2-3 minutes, and in general no gas bubble should
be seen in the pulmonary artery at 20-30 seconds after the injection.
Thanks to its high tolerance and solubility, the amount of injectable CO2
is virtually unlimited, as long as the operator allows sufficient time for its
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Figure 1.5: Percent area decrease of CO2 and air bubbles in the right atrium, after
intravenous injection of 5cm3 [9].
clearance (it is considered safe to inject quantities up to 100cc with intervals
of minimum 2 minutes between injections).
The use of CO2 still requires some fundamental precautions.
As studies have indicated its possibile neurotoxicity, CO2 should never be in-
jected in the cerebral arterial circulation. For safety reasons, arterial studies
are generally limited to below the diaphragm.
The delivery of CO2 in the vascular system is further complicated by its
gaseous properties. First of all, CO2 is a colourless and odourless gas, and
as such it cannot be visually distinguished from air. This is one of the most
important issues with this technique, as accidental air contamination could
cause serious complications such as air embolism.
Taking into consideration its buoyancy, CO2 is never to be injected in the
prone position (to avoid spinal cord ischemia) nor with the patient’s head
in an elevated position. Important adverse effects are related to the “vapor
lock” phenomenon, when the gas is struck and obstructs the normal blood
flow. This is usually due to the accidental injection of an eccessive volume of
CO2, and might lead to ischemia or heart failure. In case CO2 gets trapped
it is important to rotate the patient, thus releasing the trapped gas and re-
establishing the blood flow.
It should also be noted that CO2 is compressible during injection and it sud-
denly expands at the exit of the catheter, resulting in an “explosive delivery”.
Nevertheless studies have shown that real damage risk for the patient is not
due to the gas jet from the catheter but to the local pressure rise, due to the
sudden gas input in the elastic vascular chamber [12].
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This local increase of pressure might be one of the causes of the transient
pain or discomfort that some patients complain after CO2 injections, along
with the temporary acidosis due to the increase of carbonic acid in the blood.
Delivery systems
Considering these technical issues, the choice of a good delivery system
is of fundamental importance to reduce the possible risks and allow a better
control on the injection, and thus on the final images.
Initially, a handheld syringe system was used: a syringe was directly filled
from a CO2 cylinder, employing a gas regulator to reduce the pressure. This
technique holds a few important problems, such as the elevated risk of air
contamination. Moreover, as there is no control over the injected volume
and the injection pressure, this system will result in a highly unpredictable
delivery.
Figure 1.6: Plastic Bag Delivery System [9].
An improvement of this technique was the plastic bag delivery system
(figure 1.6). A CO2 cylinder is used to fill a plastic bag that can only con-
tain 1500cc at atmospheric pressure: this prevents the inadverted injection
of excessive volumes. The risk of air contamination is averted with the use
of multiple one-way check flow valves. This system is quite user-friendly and
undoubtedly safer than the handheld syringe, but it still requires a manual
injection. Therefore the control of the injection is heavily dependent on the
ability of the operator, and errors are possible even with experienced person-
nel.
14 CHAPTER 1. OVERVIEW OF THE PROBLEM
Figure 1.7: “Angiodroid” injector module.
Automatic injectors are quite promising, as they are virtually fail-safe.
There is no chance of delivering excessive volumes, injection pressure can be
controlled and there is no risk of air contamination.
“Angiodroid” is an automatic CO2 injector dedicated to diagnostic and
interventional angiographic peripheral procedures, produced by BioSpark Srl.
This injector allows a precise control over the injection pressure and volume
while eliminating any risk of air contamination. The main component of the
device is the injector module (figure 1.7).
CO2 is initially contained in a cylinder, from which it’s moved to a ‘loading
tank’ that can hold up to 400 ml of gas. This tank is always kept at positive
pressure, thus removing any risk of contamination: even in case of leakage
the CO2 will flow out, rather than the air flowing in. The desired volume
of CO2 is then moved to the ‘injection bag’, a soft sack that can contain
up to 100 ml. This bag is in contact with a ‘pressurized tank’ which, filled
with up to 700 ml of air, can exert an adjustable pressure on the injection
bag, thus allowing the regulation of the CO2 injection pressure. With this
delivery system the injection pressure is almost constant, as compared with
manual injections (figure 1.8).
Being an automatic system, “Angiodroid” is very user-friendly: the oper-
ator can just set the desired CO2 volume and the pressure of injection, and
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the systems automatically delivers the contrast medium. This also reduces
the training period for the operators, making CO2 DSA a more accessible
procedure.
Figure 1.8: Injection pressure as a function of time, for manual injections and with an
automatic injector [12]. Manual injections include a phase A of line washing
and B of actual CO2 injection.
1.2 Radiological systems
Interventional radiology procedures are usually performed in angiographic
suites equipped with C-arm systems called fluoroscopes. This radiological
system comprises a high power generator, an X-ray tube, an image receptor
and an automatic exposure control system. The radiological apparatus can
be set in different ways, but the most common configuration is with the X-
ray tube located under the patient table, and the imaging equipment above
the patient. Fluoroscopes can be both floor-mounted or mobile. Mobile fluo-
roscopes are useful when they need to be moved between locations, but they
are generally less powerful (about 15kW instead of circa 100kW).
These radiological systems have multiple operating modes, to adapt their
function to the operative diagnostic and therapeutic needs, and can perform
both fluoroscopy and radiography.
Fluoroscopy is used to monitor the introduction of catheters and guides
through the vascular system to the desired location. For this purpose, a
limited photon flow is sufficient, so the X-ray tube operates in a continuous
mode with a current of a few mA (usually up to 5 mA).
When a detailed description of vascular chambers is needed, the photon
flow is increased by rising tube current, and the emission changes from con-
tinuous to impulsive. This is the true angiographic phase, which uses currents
up to 1000 mA and frame rates up to 50 fps with frame lengths varying from
a few to about 40 ms. A pulsed emission may also be applied to fluoroscopy:
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the introduction of pulsed fluoroscopy reduces patient dose while improving
image quality, as it avoids unnecessary exposition while allowing the use of
greater dose rates.
Due to the complexity and length of the procedures, which can easily take
up to more than one hour, interventional suites need to be equipped with
powerful generators and X-ray tubes with valid cooling systems.
1.2.1 X-ray generator
The X-ray generator is the component that provides all the electrical
power sources and signals required for operating the X-ray tube, and controls
the operational conditions of X ray production. Its essential components are
a filament heating circuit to determine anode current, a high voltage supply
to accelerate the anode current electrons, a motor drive circuit for rotating
the anode and an operational control to regulate the voltage and currents.
The filament circuit heats the X-ray cathode filament according to the set
tube current. Even when not emitting, the filament is permanently preheated
to a temperature at which thermionic emission is negligible, in order to min-
imize thermal stress and increase its durability. The filament also presents a
thermal inertia, which limits the speed of changes in tube current. To allow
a fast switching of the tube current (e.g. when pulsed emission is required)
some tubes use a negatively biased grid positioned near the filament to shut
out the flow of electrons (“grid-switched” X-ray tubes).
A fundamental function of the X-ray generator is to provide a high voltage
to the X-ray tube. As the AC line voltage available in hospitals (380V three
phase) is much lower than the voltage required for X-ray production (40 to
150 kV), a voltage elevation circuit is necessary.
Modern voltage elevators use a tree step solution:
• A first circuit transforms the AC line power into DC power;
• A second circuit transforms the DC voltage into a high frequency al-
ternating PWM signal;
• A transformer receives the high frequency PWM signal and produces
a high voltage signal, which is then rectified by diodes and applied to
the tube.
The voltage is usually supplied symmetrically to the tube: for example a
potential difference of 120 kV is achieved by applying -60 kV to the cathode
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Figure 1.9: Schematic view of an X-ray generator [15].
and +60 kV to the anode. During angiography or pulsed fluoroscopy the
X-ray emission is controlled by rapid tube voltage changes or by a tube grid
interruption system. When controlling the emission by tube voltage, it is
important to reach the desired voltage in the shortest possible time. This
time is limited by the electronic circuits and by the capacitance of the high
voltage cables, resulting in a modified HV pulse with non-null rise time and
some tailing, which not only impairs the production of short pulses, but also
changes the emitted X-ray spectrum.
An operator console allows the selection of X-ray tube parameters, such
as kVp, mA, exposure time and, on some generators, the focal spot size.
For fluoroscopic systems this selection is usually piloted by the automatic
exposure control system.
1.2.2 X-ray tube
The principal components of an X-ray tube are a cathode, composed
of one or more tungsten filaments in a focusing cup, and an anode. Both
are contained inside a tube envelope to maintain an interior vacuum and,
together with a motor for anode rotation, they are contained inside a metal
housing (figure 1.10).
The current, passing in the helical filament of the cathode, controls the
thermionic emission of electrons, changing the intensity of the X-ray beam.
X-ray tubes for diagnostic images typically have two filaments of different
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Figure 1.10: Schematic view of an X-ray tube [15].
sizes, as their lengths determine the focal size. A smaller filament means
a smaller focal spot, and subsequently more detailed images. On the other
hand, a longer filament allows a better heat dispersion on the anode, thus
allowing to work with higher powers.
Most X-ray tubes have a rotating anode, commonly made of tungsten
because of its high atomic number (Z=74) and high fusion point (3422°C).
Molybdemun (Z=48) and rhodium (Z=45) anodes are also used for specific
applications, such as mammography.
The area of the anode hit by the electrons should be as large as possible, in
order to keep the power density within acceptable limits. The anode is angled
to balance this need with the goal of obtaining a small focal spot size, for the
line focus principle: the “effective” focal spot length is much smaller than
its “true” length, as shown in figure 1.11, and the corresponding geometrical
relation is:
“effective” focal length = “true” focal length · sinθ
where θ is the anode angle.
These elements are enclosed in a glass envelope under a high vacuum.
This is then contained within a X-ray tube housing filled with oil, which
supports, insulates, and protects the X-ray tube insert from the environ-
ment. The housing also contains lead shields to attenuate the X-ray that are
emitted in directions other than the desired one.
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Figure 1.11: Line focus principle [15].
X-ray beam filtering changes the shape of the spectrum. The X-ray beam
is subject to some filtration caused by the tube itself, such as the one due
to the glass or metal insert at the x-ray tube port. Besides this inherent
filtration, an added filtration is usually included in order to selectively re-
move some components of the spectra. Low energy components are usually
eliminated, as they are not useful for image formation but just increase the
patient dose.
Different emission parameters further change the beam characteristics.
Radiation quality refers to the beam’s penetrating ability. As it is tied to
the spectrum shape, it can be changed with tube voltage, which determines
the maximum energy in the spectrum. X-ray beam quality is often expressed
by its half-value thickness (HVL) in mmAl. The beam intensity depends on
the number of electrons emitted from the cathode and their energy, thus it
is influenced by tube voltage, anode current and exposure time (X-ray beam
intensity is roughly I ∝ kVp2· mAs [15]).
The energy incident on the anode causes a buildup of heat which, if
not efficiently dissipated, might cause anode rupture. The nominal anode
input power is P = kV × mA, considering the tube voltage and the anode
current. Heat dissipation occurs by irradiation, following Boltzmann’s law.
Each X-ray tube has a graph with its anode heating and cooling curves for
different applied powers, as they can greatly vary from tube to tube. For
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example, comparing two different tubes (figure 1.12 and figure 1.13) we can
see that the stored energy is on a completely different scale (maximum 225 kJ
versus more than 2500 kJ).
Along with this graph, each equipment should be provided with two
graphs of the heating and cooling curves of the X-ray tube assembly, a “pas-
sive” one and and “active” one in case a cooling system in function.
Figure 1.12: Anode heating and cooling curves for RTM 70 H [23].
Figure 1.13: Anode heating and cooling curves for Performix 160 A [24].
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1.2.3 Image detectors
X-ray image intensifiers
The introduction of X-ray image intensifiers (II) in the early 1950s revo-
lutionized the use of fluoroscopy in clinical diagnosis, making it possible to
obtain continuous X-ray imaging at reasonable exposure.
Image intensifiers are vacuum tube devices that, with a three-stage con-
version and amplification process (figure 1.14), can convert low intensity
X-ray photon fluence exiting the patient into a high fluence of visible pho-
tons. The most commonly used scintillator is thallium-doped cesium iodide
(CsI:Tl), which is usually grown as needle-shaped crystals with 5-10 µm in
diameter. This structure acts as a light-guide, reducing the scattering of the
light during its path to the photodiode, thus increasing spatial resolution.
X-ray photons strike the CsI input phosphor, where they are absorbed and
produce a large number of visible light photons. A photocathode produces a
corresponding number of electrons, which are accelerated and focused as to
impact on the output phosphor. This collision results in the emission of light
photons that can be recorded by a video camera, and the resulting image
accurately represents the X-ray distribution incident at the input window.
Figure 1.14: Schematic view of an image intensifier [14].
This systems holds many potential sources of error. The input phosphor
needs to be curved to withstand external atmospheric pressure, but mapping
a curved input surface onto a flat output surface leads to a spatial distortion
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at the periphery of the image (pin-cushion distortion). Furthermore, elec-
trostatic and magnetic focusing gradients may interact with magnetic fields,
causing transient spatial ‘S’ distortions. The images also present vignetting
caused by light scattering from the output phosphor. This also causes veiling
glare, which reduces the overall image contrast. Spatial resolution is deter-
mined by the video camera system and the magnification mode of the field
of view. Even though the II has a linear light intensity response over a very
wide range of incident exposures, this is not true for the video cameras, and
some of the image information content is lost by saturation or threshold of
the signals.
Flat panel detectors
Flat panel detectors (FD) were first introduced in the late 1990s, and had
a widespread diffusion due to their ability to cover the various requirements
of different applications, ranging from general radiography to mammography
and fluoroscopy [17]. In particular, in interventional radiology, they have
almost completely substituted the image intensifier systems.
The central component of flat-panel detectors is an active matrix of hy-
drogenated amorphous silicon (a-Si:H), with a pixel structure of photodiodes
and thin-film transistors (TFT). The conversion process of X-ray radiation
into electric charge can be of two different types: an indirect conversion
process, in which the X-ray radiation is first converted into light, which then
creates electric charge, and a direct conversion of X-ray into electrical charge.
Figure 1.15: Schematic view of an indirect converting flat detector based on CsI and an
amorphous silicon active readout matrix [17].
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The most widely used type of conversion is the indirect process, with CsI
as scintillator material (figure 1.15). The X-ray quantum is absorbed creating
a high-energy electron via photo absorption. This electron looses energy in
the scintillator material creating a large number of electron-hole pairs, which
in turn recombine to produce photons in the visible range. This light is then
converted to electric charge when it hits the photodiode, which is designed
to reach a high quantum efficiency in the green part of the visible spectrum
to match the spectrum of the scintillation light. After each exposition, the
pixel circuit performs a row by row readout, and the signal is fed to an
analog-to-digital converter.
Flat panel detectors possess several advantages over image intensifiers,
like better image uniformity, no veiling glare or vignetting, and small, thin
physical size. Geometric distorsion is not an issue, as FDs are not influenced
by magnetic fields and there are no curved surfaces involved. A great ad-
vantage of flat panels is their high degree of linearity for a wider dose range
than IIs. On the other hand, while this holds true for most applications
(especially for high-exposure applications like DSA), FDs are less efficient
for low exposure levels due to the increased contribution of electrical noise.
Figure 1.16 shows that the dynamic range of an image intensifier fluoroscopy
system is smaller than that of a FPD system. Other issues with FDs are
the lower spatial resolution, which is determined by the actual size of the
detector element, and the higher costs.
Figure 1.16: Graph plots the dynamic ranges of an image intensifier (dashed line) and
FPD (solid line) fluoroscopy system [19].
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1.2.4 Automatic exposure control
Radiological suites include an automatic exposure control (AEC) system
to automatically adjust the irradiation parameters to deliver a constant signal
intensity in response to different patient thicknesses, X ray tube energies,
focus to detector distances and other technical factors.
Usually, AEC systems sense the light output using a sensor (such as a
photodiode or a photomultiplier) or the detected image itself, and this signal
is used in a feedback circuit to the X-ray generator to regulate its parame-
ters. For fluoroscopic systems, AEC changes tube voltage and anode current.
In some pulsed-fluoroscopy systems, AEC might also regulate pulse widths.
The selection of the parameters follows predetermined curves that are stored
in the generator and which usually allows for some choices, including a stan-
dard curve, low dose curve and high contrast curve (figure 1.17).
Figure 1.17: An example of typical control curves for an AEC system [14].
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1.3 Radioprotection in medical exposures
The International Commission on Radiological Protection (ICRP) is an
independent international organisation founded in 1928 to provide guidance
on protection against ionising radiation. Legislations, guidelines and pro-
grammes on radiation protection are based on ICRP’s reports and recom-
mendations. The latest recommendations are contained in “The 2007 Rec-
ommendations of the International Commission on Radiological Protection”
(ICRP Publication 103 [20]), which are un update of the 1990 version (ICRP
Publication 60).
Radiological protection is based on three principles: the principle of jus-
tification, the principle of optimisation of protection and the principle of
application of dose limits. The first two apply in all situations, while the
latter only applies in cases of planned exposure.
• The principle of justification: Any decision that alters the radiation
exposure situation should do more good than harm.
• The principle of optimisation of protection: The likelihood of
incurring exposures, the number of people exposed, and the magni-
tude of their individual doses should all be kept as low as reasonably
achievable, taking into account economic and societal factors.
• The principle of application of dose limits: The total dose to any
individual from regulated sources in planned exposure situations other
than medical exposure of patients should not exceed the appropriate
limits recommended by the Commission.
The document distinguishes three types of programmed exposures: occupa-
tional exposures, public exposures, and medical exposures of patients. The
latter mainly indicates exposures to patients undergoing diagnostic exami-
nations, interventional procedures, or radiation therapy.
Medical exposure has to be handled with a different approach compared to
the others cases, because it is intentional and directly benefits the patient.
For the principle of justification it is important to make an accurate eval-
uation of every medical procedure involving radiation exposure. As it is now
generally accepted that the use of radiation in medicine does more good than
harm to the patients, the evaluations focus on determining whether a spe-
cific radiological procedure will usually improve the diagnosis or treatment.
It is then necessary to make a risk-benefit evaluation of the procedure for
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individual patients (e.g. checking that the proposed procedure is the most
suitable method, or that the required information is not already available).
After a procedure has been appraised as justified, it is the turn of its
optimisation. It is important to remember that, especially in the medical
field, optimisation of protection is not minimisation of dose, hence the best
option is not necessarily the one with the lowest dose.
In the case of radiation therapy, an optimised procedure delivers the pre-
scribed dose to the tumour while protecting as much as possible the healthy
tissues outside the target volume. In diagnostic and interventional proce-
dures, optimisation involves keeping doses as low as reasonably achievable
without defeating the purpose of the procedure.
ICRP does not recommend the application of dose limits for medical ex-
posures, as they may do more harm than good by reducing the effectiveness
of the treatment or diagnosis. Instead of limits, the document suggests the
assessment of diagnostic reference levels as a term of comparison to indicate
whether the levels of patient dose are unusually high or low for that pro-
cedure. In such cases, it is necessary to re-evaluate the optimisation of the
procedure.
1.3.1 Dosimetric quantities
The fundamental physical quantity in radiation biology, clinical radiology,
and radiological protection is the absorbed dose, D, defined as the mean
energy imparted to a unitary mass by ionising radiation.
D =
dεads
dm
The absorbed dose is not the same as the kerma, K, which is defined
as the mean energy transferred from indirectly ionizing radiation to charged
particles in the mass dm.
K =
dεtr
dm
As kerma may be defined in any material, it is important to declare the
material considered (e.g. air kerma).
The SI unit for both absorbed dose and kerma is the gray (1 Gy = 1 J ·kg−1),
but the two quantities are not equivalent as the energy transfer from the
primary photon does not happen in the same place of the energy deposition
in the material.
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Kerma and absorbed dose have the same value only in condition of elec-
tronic equilibrium, in which the charged particles that are released in a vol-
ume dV and the ones that leave the volume are balanced. In case of unat-
tenuated photon beams this condition is met after a certain depth, called
build up region, of the order of the charged particle range in the material.
In a more realistic situation the attenuation of the photon beam cannot be
neglected and, after the build up region, we reach a state of transient elec-
tronic equilibrium in which both kerma and absorbed dose decrease with
depth. For this approximate electronic equilibrium to subsist, the X-ray at-
tenuation must be very small: for water and soft tissues, this is certainly the
case for primary photons with energies from 0.1 to 0.5 MeV, and it increases
exceeding 5% at 3 MeV [13].
As the absorbed dose cannot be measured, it is usually calculated from
other quantities. In case of equilibrium between kerma and absorbed dose:
D = K(1− g)
where g is the fraction of energy that is lost to bremsstrahlung.
In practice, the absorbed dose values are averaged over tissue volumes, usu-
ally over the mass of a specified organ or tissue.
The equivalent dose is a quantity that takes in consideration the biological
effectiveness of the type and energy of radiation:
HT =
∑
R
wRDT,R
where wR is the radiation weighting factor for radiation R, as determined
ICRP on the basis of experimental data.
The effective dose is a quantity that represents the risk of stocastic effects,
and is defined as a weighted sum of the equivalent doses of the various tissues.
E =
∑
T
wTHT =
∑
T
wT
∑
R
wRDT,R
where wT is the tissue weighting factor for tissue T. These factors represent
the contributions of individual organs and tissues to the overall radiation
detriment from stochastic effects as determined by ICRP on the basis of epi-
demiological studies, and they are
∑
wT = 1. The SI unit for both equivalent
dose and effective dose is the sievert (1 Sv = 1 J · kg−1).
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For what concerns medical exposures, the assessment of patients’ doses
is of fundamental importance not only for risk-benefit evaluations, but also
in order to understand the factors that affect the exposure and to devise
effective techniques for its reduction.
In many cases patient dose is described using the entrance surface dose
(ESD), defined as the absorbed dose measured on the patient’s skin at the
center of the X-ray beam, or in terms of incident air kerma, without the
contribution of backscattered radiation.
Another common quantity is the dose area product (DAP), which is widely
used because it is correlatable to the absorbed dose and it can be easily
measured with a DAP chamber without interfering with the patient or the
procedure. DAP is usually expressed in mGy · cm2 and is defined as the
integral of the absorbed dose over the area of the X-ray beam in a plane
perpendicular to the beam axis:
DAP =
∫
A
D(x, y)dxdy
In the approximation that the absorbed dose does not vary across the field,
this is equal to the product of the absorbed dose and the field area [14].
It is very useful thanks to its property of being approximately independent of
the distance from the source, when interactions in air and extrafocal radiation
can be neglected, as the dose decreases with the square of the distance while
the field area increases with the square of the distance (figure 1.18).
Exploiting this property the DAP chamber is positioned at the exit of the
X-ray tube to encompass the whole radiation field, and the value measured
in that point should be the same as the value at the entrance of the patient.
Figure 1.18: Dose area product is independent of distance.
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These quantities are adequate where the X-ray exposure conditions are
constant, for example for quality control of equipment.
However this is not sufficient for the comparison or the assessment of
patients’ doses if the irradiation conditions (the size of the patient, the radi-
ation quality, the exposed body-part, or other factors) are changed.
For some purposes, the risk of stochastic harm from ionising radiation can be
simply reported with the effective dose. However its assessment and inter-
pretation is problematic when the exposure is partial or very heterogeneous,
which is the case of most medical procedures, hence it is preferable to eval-
uate the risks for individual organs or tissues using the mean absorbed doses
or equivalent doses [20].
One of the main issues with both organ doses and the effective dose is that
they cannot be measured directly in patients undergoing X-ray examinations.
It is possible to obtain experimental measurements using physical phantoms,
but the process can be laborious and time consuming. Hence, it is common
to calculate these quantities, generally using the Monte Carlo method. The
values obtained are reasonably accurate, as the physical interactions between
radiation and matter are sufficiently well-known, and the accuracy of the cal-
culation is limited mainly by the accuracy of the anatomical model used to
describe the patient and by the characterisation of the applied radiation field.
1.3.2 Radioprotection for IR procedures
Interventional radiology procedures, such as angiographies, are charac-
terised by high level of doses to both patient and medical staff. This is due
to the long fluoroscopy time and the large number of radiographic frames
per examination. In addition to the increased likelihood of stochastic effects,
particularly long procedures might cause deterministic radiation injuries.
The planning of such procedures should follow a guideline for the radia-
tion dose management, such as the one proposed by the Society of Interven-
tional Radiology [22]. Preprocedural preparations should include individual
training of the operators, periodical quality assessment of the equipment and
careful procedure planning. During the procedure, in accordance with the
acting regulations, the operators should constantly monitor the radiation
dose through quantities such as DAP and fluoroscopy time. In any case, all
the possible dose minimization techniques should be put in action. After the
procedure, the estimated patient dose or the measured dose values should
be recorded in the patient’s medical record. Patients that have received par-
ticularly large doses of radiation should be subjected to additional clinical
follow-ups.
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CHAPTER 2
Materials and methods
2.1 Experimental setup
To take some preliminary measures we used an X-ray tube, the IAE RTM 70 H,
which is placed in a bunker at the Centre of Medical Physics of the Bologna Uni-
versity Hospital Authority St.Orsola-Malpighi Polyclinic (figure 3.1).
Manufacturer: IAE
Name: RTM 70 H
Power: 25 kW
Voltage range: 40 ÷ 130 kV
Current range: 0.5 ÷ 140 mA
Focal spot size: 0.3/0.6 mm
Anode angle: 10°
Total filtration: 1.5 mmAl
Table 2.1: Technical data of IAE RTM 70 H.
2.2 Fluoroscopy suites
To study the different irradiation parameters applied by different equip-
ment we worked on 3 different fluoroscopy suites from different manufactur-
ers, all in use at the the St.Orsola-Malpighi Polyclinic.
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2.2.1 Ziehm Vision RFD
The first fluoroscopic equipment we considered is a Ziehm Vision RFD
mobile fluoroscope. As it is wheel-mounted, it can be easily moved from
room to room, but it is less powerful than the other considered suites.
Manufacturer: Ziehm
Name: Vision RFD
Generator: VISION R-200
Power: 20 kW
Voltage range: 40 ÷ 120 kV
Current range: 0.5 ÷ 140 mA
Tube insert: RAD 15
Focal spot size: 0.3/0.6 mm
Anode angle: 10°
Total filtration: 5 mmAl
Image detector: PaxScan 3030
Detector type: flat panel
Detector size: 30 × 30 cm
Table 2.2: Technical data of Ziehm Vision RFD.
Figure 2.1: Ziehm Vision RFD.
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2.2.2 Siemens ANGIOSTAR
Siemens ANGIOSTAR is a floor-mounted fluoroscope that comes with
an image intensifier as image detector. This equipment does not have a
CO2-specific program, so we studied its behaviour for the traditional periph-
eral DSA protocol.
Manufacturer: Siemens
Name: Angiostar
Generator: POLYDOROS IS
Power: 100 kW
Focal spot size: 0.3/0.6/1 mm
Anode angle: 12°
Total filtration: 8 mmAl
Image detector: Sirecon 40-4 HD
Detector type: image intensifier
Detector size: 40 × 28 cm
Table 2.3: Technical data of Siemens Angiostar.
Figure 2.2: Siemens ANGIOSTAR.
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2.2.3 GE Innova IGS
GE Innova IGS is a powerful angiographic system, with a powerful gen-
erator and a flat panel image detector. Its anode heating and cooling curves
are shown in figure 1.13.
Manufacturer: GE
Name IGS Innova
Generator JEDI 100
Power 100 kW
Voltage range 40 ÷ 150 kV
Current range 10 ÷ 1000 mA
Tube insert Performix 160 A
Focal spot size 0.3/0.6/1 mm
Anode angle 11°
Total filtration 1.8mmAl+0.2mmCu
Detector type flat panel
Detector size 31 × 31 cm
Table 2.4: Technical data of GE Innova IGS.
Figure 2.3: GE Innova IGS 530.
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Comparison chart
This is a simple chart for the comparison of the three fluoroscopy suites:
Manufacturer: Ziehm Siemens GE
Name: Vision RFD Angiostar Innova IGS
Power: 20 kW 100 kW 100 kW
Focal spot size: 0.3/0.6 mm 0.3/0.6/1 mm 0.3/0.6/1 mm
Anode angle: 10° 12° 11°
Total filtration: 5mmAl 8mmAl 1.8mmAl+0.2mmCu
Image detector: flat panel image intensifier flat panel
Detector size: 30 × 30 cm 40 × 28 cm 31 × 31 cm
Table 2.5: Comparison chart for the considered fluoroscopes.
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2.3 Barracuda
Figure 2.4: Barracuda data processing cabinet and MPD.
“Barracuda” by RTI Electronics is an extremely versatile X-ray multime-
ter that can be used as a quality assurance system. It is a modular instrument
whose main parts are a data processing cabinet, a Multi-Purpose Detector
(MPD) and a computer with the oRTIgo software. The MPD is a universal
semiconductor detector for all types of X-ray systems, and can measure tube
voltage, exposure time, dose, dose rate, dose/pulse and pulse rate, total fil-
tration, quick HVL estimation, kVp waveform and dose rate waveform.
Table 2.6 lists the MPD measuring ranges and inaccuracies, as stated on
its manual [25].
Range Inaccuracy
kVp: 35 - 155kV ±1.5%
Irradiation time: 0.1ms - 2000s ±1% or ±0.5ms
Dose rate: 0.2µGy/s - 1000Gy ±5% or ±0.02µGy/s
Estimated HVL: 1.2 - 14mmAl ±10% or ±0.2mm
Table 2.6: MPD measuring ranges and inaccuracies.
When recording waveforms the sampling rate is inversely proportional to
the acquisition time, as the memory size is limited. The recording time can
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span from 320 ms (with a sampling rate of 2000 times per second) to 41 s
(with 16 acquisitions per second). The recording can be triggered manually
or by the system, usually with the start of the irradiation. When trigged by
the system, the waveforms will be stored from the start of the exposure to
the maximum recording time stated below, or until the end of the exposure
if the exposure is finished before the memory is full.
2.4 SpekCalc
The X-ray spectrum and beam quality are fundamental parameters for
studying the dosimetric properties of X-ray beams in medical physics. Di-
rect measures of the true spectral photon fluence require a spectrometer and
careful set-up planning. For most uses, therefore, X-ray prediction models
are usually applied.
SpekCalc is a software program for the calculation of X-ray spectra from
tungsten anode X-ray tubes. It can simulate a wide range of tube voltages
(40-300 kVp) and anode angles (6-30°), with filters of seven possible materials
(air, water, Be, Al, Cu, Sn and W). In addition to the simulated spectrum,
the GUI also shows the 1st and 2nd HVL in both mmAl and mmCu, the mean
energy of the spectrum, the effective energy for Al and Cu and the estimated
bremsstrahlung and characteristic contributions to the tube output.
Its theoretical approach was developed by Gavin Poludniowski and Phil
Evans at The Institute of Cancer Research of London [28, 29]. This model
combines numerically pre-calculated electron distributions with deterministic
equations, based on theoretical results for the bremsstrahlung cross sections.
Despite its limitation, due to some simplifying assumptions, this program
represents a valid alternative to a full Monte Carlo treatment of the problem
[30], and its predictions are comparable to experimental measures [31].
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CHAPTER 3
Results
3.1 Evaluation of X-ray attenuation with PMMA
Firstly, we evaluated the attenuation of X-ray beams with different thick-
nesses of PMMA, which is the material we chose for the phantom in the
subsequent measures.
Using the X-ray tube RTM 70 H we recreated five standard RQR beams,
based on the IEC normative 61267:2005-11 [27]. RQR beams represent a
standard for radiation beams emerging from the X-ray tube, and table 3.1
indicates the tabulated values for radiation qualities of the considered beams.
Radiation quality Tube voltage (kV) HVL (mmAl)
RQR2 40 1.42
RQR4 60 2.19
RQR6 80 3.01
RQR8 100 3.97
RQR9 120 5.00
Table 3.1: RQR beam qualities as tabulated in the IEC normative [27].
The required beams were recreated choosing an appropriate added alu-
minium filtration for each tube voltage, and evaluating the resulting exper-
imental beams using the Barracuda MPD dosimeter. Table 3.2 shows the
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obtained values, with their errors due to the Barracuda reading inaccuracy,
which are in good agreement with the required values.
Voltage(kV) HVL(mmAl) Added filter(mmAl)
RQR2 (40.5± 0.6) (1.38± 0.14) 1.8
RQR4 (60.7± 0.9) (2.2± 0.2) 1.5
RQR6 (79.8± 1.2) (3.1± 0.3) 1.8
RQR8 (101.6± 1.5) (4.0± 0.4) 2.2
RQR9 (121.1± 1.8) (5.1± 0.5) 2.3
Table 3.2: Experimental beam qualities measured with the Barracuda dosimeter, and their
respective added filtration.
Figure 3.1: The considered setup, composed of the RTM 70 H X-ray tube, PMMA slabs
and the Barracuda MPT dosimeter, secured on a flat panel.
These RQR beams were then attenuated with an increasing number of
PMMA slabs, with a depth of 2 cm each, to evaluate their attenuation. This
setup is shown in figure 3.1. Figure 3.2 shows for each beam the attenuation
of the dose rate, measured with the Barracuda dosimeter, as function of the
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thickness of the inserted PMMA slabs. The results cannot be fitted with an
exponential interpolation, as the beams are not monoenergetic.
Figure 3.2: Dose rate attenuation with increasing PMMA thickness.
From the obtained data, it is possible to calculate the thickness of PMMA
necessary to produce beams with the same radiation quality of RQA beams,
which are the standard for attenuated beams as tabulated in the IEC nor-
mative [27]. The HVL of each beam increases linearly with the thickness of
the PMMA phantom. With a linear interpolation, we can easily extract the
thickness of PMMA that gives a beam with a certain HVL.
Radiation quality HVL (mmAl) Required PMMA (cm)
RQA2 2.2 8.6
RQA4 5.4 26.6
RQA6 8.2 33.4
RQA8 10.1 36.2
RQA9 11.6 41.4
Table 3.3: Thickness of PMMA required to produce RQA beams.
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3.2 Measures on radiological systems
Radiological suites from different firms implement different programs, and
as such they might operate differently for the same situation. We are in-
terested in investigating how different equipments perform fluoroscopy with
DSA, in both traditional and CO2-specific program. The inspected equip-
ments operate on pulsed-mode, allowing the operator to choose a determinate
pulse rate (in frames per second).
To analyze the behavior of different radiological suites, we recreated the
same set-up on all the apparatus: in stead of the patient we put a phantom
made of 12 cm of PMMA slabs, positioning the dosimeter on its side. We
acquired the dose rate waveforms with the Barracuda MPD dosimeter, set to
a maximum recording time of 3 seconds after the beginning of the exposure,
with a sampling rate of 250 per second.
3.2.1 Ziehm Vision RFD
On the Ziehm equipment, set up as in figure 2.1, we measured the irra-
diation for DSA fluoroscopy with 25, 12.5, 8 and 4 frames per second and
for both traditional and CO2 program. Figure 3.4 shows the dose-rate wave-
forms for the traditional DSA fluoroscopy, while figure 3.5 represents those
for the CO2-specific program.
We found that, with the considered set-up, the equipment irradiates with
the same parameters for all settings, as shown in table 3.4.
ICM CO2
fps kVp mA ms kVp mA ms
25 67 58.8 20 67 58.8 20
12.5 67 58.8 20 67 58.8 20
8 67 58.8 20 67 58.8 20
4 67 58.8 20 67 58.8 20
Table 3.4: Emission parameters obtained on Ziehm Vision RFD.
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The pulse lengths were determined by fitting a pulse wave to the wave-
forms, as can be seen in figure 3.3: in this case we have 20 ms long pulses
with intervals of 60 ms, thus 12.5 pulses per second.
Figure 3.3: A close-up of some pulses from the traditional DSA acquisition with 12.5 fps
on Ziehm equipment, with a pulse wave fit.
In the dose rate graphs we can clearly distinguish two emission phases:
the first phase is the acquisition of the mask image, while the real DSA ac-
quisition starts after it. It is worth noting that the mask is always acquired
with 25 frames per second, regardless of the selected pulse rate. Of all the
considered systems, this is the only one in which this happens.
An interesting remark can be made on the 12.5 fps sequence for CO2
(second graph on figure 3.5). As this was actually the first acquisition on
this equipment, we can observe the automatic exposure control at work: at
the beginning, the tube voltage is clearly changing, and the mask acquisition
starts only after the voltage has stabilized at around 67 kV.
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Figure 3.4: Dose rate waveforms for traditional DSA measured on Ziehm Vision RFD with
25, 12.5, 8 and 4 fps.
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Figure 3.5: Dose rate waveforms for CO2 DSA measured on Ziehm Vision RFD with 25,
12.5, 8 and 4 fps.
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3.2.2 Siemens ANGIOSTAR
Since the Siemens ANGIOSTAR equipment does not have a CO2-specific
program, we just analyzed its emission with the DSA fluoroscopy program
for traditional contrast agents, with 6 and 4 frames per second. The set up
is shown in figure 2.2. The emission parameters are shown in table 3.5 , and
the obtained dose-rate waveforms are shown in figure 3.6.
Looking at the waveforms we can see no clear phases as in the Ziehm
equipment, hence we infer that the mask is acquired at the pulse rate selected
by the operator.
ICM
fps kVp mA ms
6 71 237 60
4 70 302 48
Table 3.5: Emission parameters obtained on Siemens Angiostar.
Figure 3.6: Dose rate waveforms for traditional DSA measured on Siemens ANGIOSTAR
with 6 and 4 fps.
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3.2.3 GE Innova IGS
The same measurements were performed on the GE equipment, set up
as shown in figure 2.3, with pulse rates 7.5 and 4 frames per second. The
dose-rate waveforms for the traditional DSA fluoroscopy are shown in figure
3.7, while figure 3.8 represents those for the CO2-specific program.
As in the Ziehm equipment, even here we found no actual difference
between the traditional DSA and the CO2 DSA programs. In this case,
however, the emission parameters changed for different pulse rates (table 3.6).
Once again we can see no clear phases in the waveforms, thus the mask
is acquired at the selected pulse rate.
ICM CO2
fps kVp mA ms kVp mA ms
7.5 83 144 42 83 144 42
4 81 160 42 81 160 42
Table 3.6: Emission parameters obtained on GE Innova IGS.
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Figure 3.7: Dose rate waveforms for traditional DSA measured on GE Innova IGS with
7.5 and 4 fps.
Figure 3.8: Dose rate waveforms for CO2 DSA measured on GE Innova IGS with 7.5 and
4 fps.
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3.3 Results comparison
The first evident result is that for both the Ziehm and the GE equipment,
there was no difference whatsoever in the irradiation parameters between the
traditional contrast media DSA and the CO2-specific DSA protocols.
Table 3.7 presents the emission parameters of the two apparatus for both
protocols, at a frame rate of 4 fps.
ICM CO2
(4 fps) kVp mA ms kVp mA ms
Ziehm 67 58.8 20 67 58.8 20
GE 81 160 42 81 160 42
Table 3.7: Emission parameters for ICM and CO2 on Ziehm and GE, for 4 fps.
Comparing our measures, we can observe how the three fluoroscopes
choose different parameters for the same set-up. We choose to analyze in
particular the results obtained for a frame rate of 4 fps, as it is present in all
of the equipment.
Table 3.8 shows a direct comparison of the emission parameters.
Ziehm Siemens GE
kVp (kV) 67 70 81
Current (mA) 58.8 302 160
Pulse (ms) 20 48 42
Table 3.8: Comparison of the emission parameters for a frame rate of 4 fps.
The corresponding emitted X-ray spectra for a single pulse were simu-
lated with the SpekCalc software (figure 3.9), and table 3.9 indicates their
mean features. It is immediately clear that the three equipment administer
very different doses for a single frame.
The photon density produced by the Ziehm equipment is significantly
lower than the other equipment, and this is attributable to its less powerful
generator. In fact, it uses the lowest voltage of the three fluoroscopes, the
lowest current (less than one fifth of the one set by Siemens), and it has the
shortest pulse (less than half of the others).
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Figure 3.9: Simulated spectra for the three fluoroscopes, for 4 fps.
Ziehm Siemens GE
HVL (mmAl) 3.4 4.4 5.3
Mean energy (keV) 42 46 51
Peak energy (keV) 38 42 46
Table 3.9: Characteristics of the analyzed spectra.
Siemens equipment uses a similar voltage, but with an elevated current
and long pulse lengths (48 ms for 4 fps, 60 ms for 6 fps). Due to a higher
filtration, its mean energy is higher than the Ziehm spectrum.
On the other hand, the GE fluoroscope sets a higher tube voltage, com-
bined with an added Cu filtration.
Another important difference is the mask acquisition process. While
Siemens and GE DSA programs execute the mask acquisition at the frame
rate selected for the actual image acquisition, Ziehm uses the same high
frame rate setting (25 fps) in any case. This might be done with the intent
of obtaining a good mask image, to make up for the lower image quality
obtainable with its limited power.
CHAPTER 4
Discussion
Along with the risk of air contamination and the technical difficulties of
injecting a gaseous contrast material, one of the most common disincentives
to the diffusion of CO2 DSA in clinical practice is the concern about the
administered dose. Considering that CO2 provides less contrast than tradi-
tional ICM, in fact, it is generally believed that CO2 DSA requires a higher
dose than traditional angiographies.
To study the dosimetric aspects of CO2 DSA, we decided to start by
analysing how different fluoroscopy equipment set their irradiation conditions
for this procedure.
Due to the characteristics of this contrast medium, we expected to find
that equipment with CO2-specific protocols would elevate the administered
dose so as to make up for the lower image contrast.
Our results on two different machines (see table 3.7), however, show that
the irradiation parameters were left completely unchanged between the tra-
ditional and CO2 angiographic programs. This leads us to think that these
CO2 protocols do not operate on the X-ray emission, but only differ on an
image manipulation level to enhance the obtained results.
These measures disprove the hypothesis that, on currently employed equip-
ment, CO2 angiography is intrinsically more dose-heavy than traditional
DSA. For the present state of affairs, therefore, the problem of dose eval-
uation for CO2 DSA procedures can be assimilated to the evaluations for
traditional angiography, which have been widely discussed in literature.
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The only parameter that could lead to an actual increment of patient
dose is an augmented fluoroscopy time. This increment, if indeed present,
might be due to the clinical staff’s lack of experience with CO2 injection
and its technical difficulties, therefore requiring multiple repetitions of the
acquisitions.
The emission parameters are set by the automatic exposure control sys-
tem of the respective equipment, and their choice is a trade-off between
administered dose and image quality. These parameters are generally opti-
mized for traditional ICM. However, CO2 is quite different from traditional
contrast media for both X-ray absorption characteristics, such as the absence
of a K-edge (figure 1.2), and for its dynamical and mechanical characteristics.
Therefore, the next question we addressed was whether the irradiation
parameters were left unchanged from the traditional protocols for reasons of
technical and economical convenience (e.g. a new emission protocol requires
development funds and, moreover, an increase of maintenance complexity
and costs), or whether they were the result of a CO2-specific optimization
process (e.g. changes in emission parameters did not give significant improve-
ment of the obtainable images).
We believe that there is room for further researches and improvements on
the choice of the optimal emission parameters for CO2 DSA. In fact, even in
the case of the widely-studied traditional contrast media, different equipment
use different parameters.
Emission spectra for DSA are traditionally set considering the use of io-
dinated contrast media, hence they try to maximize the emission at energies
corresponding to a higher iodine-tissue contrast. Considering that CO2 does
not have such limits, as it doesn’t have a K-edge, and considering that modern
flat panel detectors have wider dynamical ranges than traditional systems,
higher tube voltages could be taken into consideration. In fact, this might
give a better image quality, as photon fluence increases with the square of the
voltage, while reducing the dose absorbed by the patient. The use of higher
voltages would also represent an advantage for less powerful equipment, be-
cause reaching the same photon fluence by increasing the tube current would
require much more power (as photon fluence is roughly ∝ kVp2· mAs).
Other parameters that could be discussed are the frame rate and the
pulse length. Due to its physical properties, long pulse times were usually
considered advisable for CO2 DSA protocols, as the main interest did not lay
in the imaging of the single bubbles, but in obtaining an image of a contrail
of bubbles, realized by averaging over the length of the pulse.
Since modern fluoroscopes can perform complex image manipulations
53
without significant time lag, new protocols could be taken into consideration.
For example, we could evaluate whether acquiring with higher frame rates
and shorter pulse lengths, and then stacking the resulting images, could give
an interesting or better outcome. More complex stacking algorithms could
be tested, e.g. a thresholded algorithm that emphasizes the bubble signal by
adding where the signal exceeds a certaing threshold, while averaging if it
doesn’t.
The transit of CO2 bubbles inside the vessels could be very fast, thus
it might be captured in just a few of the images. In this case, a non-
discriminating stacking of all the acquired photograms does not represent
the best solution, and a selective addition of the interesting imaged would
be advisable. This process could even be implemented as an automatic sys-
tem, for example by selecting a ROI around the vessel and only stacking the
images in which this ROI has a change of contrast.
An important consideration on patient dose should also be made. As
already stated, the patient dose for diagnostic and interventional procedures
should be kept as low as reasonably achievable, based on a careful risk-benefit
evaluation. In some clinical cases, however, it is clear that the minimization
of dose is secondary to the need of good angiographic images. This is the case
of the growing number of senior patients with relatively short life expectancy,
serious vascular diseases with a concrete risk of gangrene, and with risk fac-
tors for contrast medium nephrotoxicity. For such patients CO2 DSA could
be the only possibility of intervention, and therefore an eventual increase in
administered dose would be negligible when compared to the clinical benefits.
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CHAPTER 5
Conclusions
The starting point of this work was the interest in the dosimetric as-
pects of peripheral digital subtraction angiographies using CO2 as contrast
medium.
Angiographic procedures are of growing importance due to the increase
of patients with vascular conditions, a rising fraction of which also has renal
diseases or other risk factors for traditional iodinated contrast media. In this
perspective, CO2 DSA is considered a valid alternative to traditional DSA.
One of the main concerns with this technique is a possible increase in patient
dose due to the lower contrast provided by carbon dioxide.
Analyzing the emission parameters for different fluoroscopic equipment,
we found that there was no difference at all between the traditional and
the CO2-specific DSA protocols. Therefore there is no evidence that, with
currently employed fluoroscopes, CO2 DSA would administer higher doses
than traditional DSA.
Considering the clinical advantages and the increasing degree of attention
on this alternative contrast medium, we deem it appropriate to take into con-
sideration an optimization of the emission parameters for the specific case of
CO2. In fact, the choice of the emission parameters in present apparatus is
optimized for the use of iodinated contrast media, and might not represent
the best choice for CO2.
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In addition to the emission parameters optimization , this work suggests
many possible future developments.
For example, fluoroscopic equipment could be studied with more com-
plex phantoms, with inserts containing the two contrast media. The use of
dynamical phantoms might allow a better analysis of the imaging of moving
CO2 bubbles.
A measurement campaign for patient dose in traditional and CO2 DSA
procedures, with particular emphasis on the fluoroscopy times, could also
provide interesting results. This would allow not only a comparison of the
two procedures, but might lead to the assessment of diagnostic reference
levels.
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